Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-amylase is a key digestive enzyme responsible for the hydrolysis of alpha-1,4-glycosidic bonds in complex carbohydrates, such as dietary starch and glycogen, into simpler sugars like maltose and dextrins [6, 8]. The fungal variant, often referred to as fungal diastase and typically derived from Aspergillus oryzae, is widely used in clinical medicine as a digestive aid [2, 5]. It serves as an enzyme replacement therapy for individuals suffering from pancreatic insufficiency, chronic dyspepsia, or other malabsorption syndromes where the body's natural production of amylase is insufficient [5, 13]. By facilitating the breakdown of starch in the gastrointestinal tract, fungal diastase helps alleviate symptoms of indigestion, including bloating, flatulence, and abdominal fullness [11, 14]. In addition to its role as a therapeutic supplement, alpha-amylase is a pharmacological target for inhibitors like acarbose, which are used to manage type 2 diabetes by slowing the digestion of carbohydrates and reducing postprandial blood glucose spikes [11, 16]. The enzyme is active across a broad pH range, making it effective in various parts of the digestive tract, including the mouth and stomach [16]. Therapeutic use of fungal diastase is generally safe, though potential side effects include gastrointestinal distress and rare allergic reactions to fungal proteins [7, 11].
Hydrolysis of alpha-1,4-glycosidic linkages in starch and glycogen; competitive inhibition of enzymatic activity to slow carbohydrate absorption and reduce postprandial glucose spikes.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-amylase (AMY).